Development and validation of the daily fatigue cancer scale (DFCS): Single-item questions for clinical practice

Baussard, Louise; Stoebner-Delbarre, Anne; Bonnabel, Laurence; Huteau, Marie-Ève; Gastou, Aurélie; Cousson‐Gélie, Florence

doi:10.1016/j.ejon.2016.12.004

Cited by 11 publications

(7 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Participants were asked about the level of physical fatigue and pain intensity via a Visual Analogue Scale (VAS), they could choose an appropriate number ranging from 0 (no) to 10 (extreme). This scale has been widely used in cancer-related fatigue and pain research [22][23][24] . In addition, participants were asked about their quality of life and the degree of satisfaction about their physical health using the World Health Organization Quality of Life-Brief (WHOQOL-BRIEF) quality of life assessment.…”

Section: Psychosomatic Characteristicsmentioning

confidence: 99%

Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic

et al. 2020

View full text Add to dashboard Cite

The current study aimed to explore mental health problems in patients diagnosed with cancer during the COVID-19 pandemic. A cluster sampling, cross-sectional survey with 6213 cancer patients was conducted in one of the largest cancer centers in China. The socio-demographic and clinical characteristics, psychosomatic conditions, interpersonal relationships and social support, COVID-19 infection-related psychological stress, and mental health status were measured. Medical conditions were extracted from patients’ electronic healthcare records. Among the 6213 cancer patients, 23.4% had depression, 17.7% had anxiety, 9.3% had PTSD, and 13.5% had hostility. Hierarchical liner regression models showed that having a history of mental disorder, excessive alcohol consumption, having a higher frequency of worrying about cancer management due to COVID-19, having a higher frequency feeling of overwhelming psychological pressure from COVID-19, and having a higher level of fatigue and pain were the predominant risk factors for mental health problems in cancer patients. However, there were only 1.6% of them were seeking psychological counseling during COVID-19. We also revealed the protective factors associated with lower risk of mental health problems among cancer patients. The present study revealed a high prevalence of mental health problems and gaps in mental health services for cancer patients, which also indicated high distress from COVID-19-elevated risks. We call for systematic screening of mental health status for all cancer patients, and developing specific psychological interventions for this vulnerable population.

show abstract

Section: Psychosomatic Characteristicsmentioning

confidence: 99%

Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Evaluations in this study were performed using a VAS that allows easy comparison before and after treatment with a single item. Other multi-item evaluation methods are in current clinical use, such as the Cancer Fatigue Scale (CFS) and the Daily Fatigue Cancer Scale [ 23 , 24 ]. The VAS was used in this study as a familiar method to evaluate various subjective experiences due to its wide score range and high sensitivity [ 25 ].…”

Section: Discussionmentioning

confidence: 99%

Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise

et al. 2021

View full text Add to dashboard Cite

Background Carnitine is related to malaise, and cisplatin is associated with decreased carnitine. The purpose of this study was to elucidate the effects of one course of induction chemotherapy (IC) for head and neck cancer on blood carnitine levels, focusing on free carnitine (FC). Methods This single-center prospective study investigated 20 patients diagnosed with primary head and neck cancer who underwent IC with cisplatin, docetaxel, and 5-fluorouracil. FC, acylcarnitine (AC), and total carnitine (TC) levels were measured before starting therapy and on Days 7 and 21 after starting IC. In addition, malaise was evaluated before and after therapy using a visual analog scale (VAS). Results All subjects were men and the most common primary cancer site was the hypopharynx (9 patients). FC levels before starting therapy and on Days 7 and 21 were 47.7 ± 2.2 μM/mL, 56.7 ± 2.2 μM/mL, and 41.1 ± 1.9 μM/mL, respectively. Compared with the baseline before starting therapy, FC had significantly decreased on Day 21 (p = 0.007). AC levels before starting therapy and on Days 7 and 21 were 12.5 ± 1.2 μM/mL, 13.6 ± 1.4 μM/mL, and 10.7 ± 0.7 μM/mL, respectively. TC levels before starting therapy and on Days 7 and 21 were 60.2 ± 2.5 μM/mL, 70.2 ± 3.3 μM/mL, and 51.7 ± 2.3 μM/mL, respectively. No significant differences in AC, TC or VAS were seen before the start of therapy and on Day 21. Conclusions After IC, a latent decrease in FC occurred without any absolute deficiency or subjective malaise.

show abstract

“…This 10-items short scale is validated in cancer patients and assess physical, emotional and cognitive fatigue. (b) The scores on the VAS fatigue (Baussard et al, 2017). This VAS is adapted on the phone application (≪ Mon Essai Patient ≫) for the study needs, while respecting its original form.…”

Section: Hypnosismentioning

confidence: 99%

Hypnosis and cognitive behavioral therapy with online sessions to reduce fatigue in patients undergoing chemotherapy for a metastatic colorectal cancer: Rational and study protocol for a feasibility study

et al. 2022

Self Cite

View full text Add to dashboard Cite

BackgroundIn metastatic colorectal cancer (CRCm), fatigue is pervasive, reduces quality of life, and is negatively associated with survival. Its course is explained in part by psychosocial variables such as emotional distress, coping strategies, or perceived control. Thus, to reduce fatigue, psychosocial interventions appear to be relevant. In some cancers, Cognitive Behavioral Therapies (CBT) reduce fatigue. Hypnosis is also used as a complementary therapy to reduce the side effects of cancer. While CBT requires specific training often reserved for psychologists, hypnosis has the advantage of being increasingly practiced by caregivers and is therefore less expensive (Montgomery et al., 2007). On the other hand, CBT and hypnosis remain understudied in the CRC, do not focus on the symptom of fatigue and in Europe such programs have never been evaluated.ObjectivesImplementing an intervention in a healthcare setting is complex (e.g., economic and practical aspects) and recruiting participants can be challenging. The primary objective will therefore be to study the feasibility of two standardized interventions (hypnosis and CBT) that aim to reduce fatigue in patients with CRCm treated in a French cancer center.Methods and designA prospective, single-center, randomized interventional feasibility study, using mixed methods (both quantitative and qualitative). A total of 60 patients will be allocated to each intervention group [Hypnosis (n = 30) and CBT (n = 30)]. Participants will be randomized into two parallel groups (ratio 1:1). Both programs will consist of 6 weekly sessions focusing on the CRF management over a period of 6 weeks. Trained therapists will conduct the program combining 3 face-to-face sessions and 3 online sessions. The feasibility and experience of interventions will be evaluated by the outcome variables, including the adhesion rate, the reasons for acceptability, relevance or non-adherence, the satisfaction, the fatigue evolution (with ecological momentary assessments), and the quality of life. All questionnaires will be self-assessment using an online application from the cancer center.DiscussionResults will highlight the barriers/facilitators to the implementation of the program and the relevance of the program to the patients, and will be used to generate hypotheses for a randomized control trial.Clinical trial registrationClinicalTrials.gov Identifier: NCT04999306; https://clinicaltrials.gov/ct2/show/NCT04999306.

show abstract

Development and validation of the daily fatigue cancer scale (DFCS): Single-item questions for clinical practice

Cited by 11 publications

References 29 publications

Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic

Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic

Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise

Hypnosis and cognitive behavioral therapy with online sessions to reduce fatigue in patients undergoing chemotherapy for a metastatic colorectal cancer: Rational and study protocol for a feasibility study

Contact Info

Product

Resources

About